Europe’s medical devices industry saw a drop of 37.50% in deal activity during August 2022

Europe’s medical devices industry saw a drop of 37.50% in deal activity during August 2022, when compared with the last 12-month average, led by Azenta’s $468.22m acquisition of B Medical Systems, according to GlobalData’s deals database.

 

A total of 25 medical devices industry deals worth $861.1m were announced for the region in August 2022, against the 12-month average of 40 deals.

Of all the deal types, M&A saw most activity in August 2022 with 12 transactions, representing a 48% share for the region.

In second place was venture financing with nine deals, followed by private equity deals with four transactions, respectively capturing a 36% and 16% share of the overall deal activity for the month.

In terms of value of deals, M&A was the leading category in Europe’s medical devices industry with $795.55m, while venture financing and private equity deals totalled $34.36m and $31.18m, respectively.

Europe medical devices industry deals in August 2022: Top deals

The top five medical devices deals accounted for 95.7% of the overall value during August 2022.

The combined value of the top five medical devices deals stood at $823.85m, against the overall value of $861.1m recorded for the month.

The top five medical devices industry deals of August 2022 tracked by GlobalData were:

1) Azenta’s $468.22m acquisition deal with B Medical Systems

2) The $170m acquisition of Curiosity Diagnostics by Bio-Rad Laboratories

3) Eurobio Scientific’s $137.14m acquisition deal with Genome Diagnostics

4) The $31.18m private equity of Pharma Tech Holding by LDA capital

5) 908 Devices’s $17.3m acquisition deal with TRACE Analytics